InsiderClue
Insiders · Profile

McFarlane Neil F.

President and CEO at ZEVRA THERAPEUTICS · Chief Operating Officer at Travere Therapeutics. Filing since 16 Aug 2017. CIK 0001681098

ZVRA ZEVRA THERAPEUTICS, INC. President and CEO · 5 trades TVTX Travere Therapeutics, Inc. Chief Operating Officer · 5 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ZVRA ZEVRA THERAPEUTICS, INC.
9 Feb 2026
President and CEO
Sold on a plan
14,625
$125.19K
3.6%
ZVRA ZEVRA THERAPEUTICS, INC.
2 Feb 2026
President and CEO
Sold on a plan
91,000
$853.43K
20.0%
ZVRA ZEVRA THERAPEUTICS, INC.
10 Oct 2025
President and CEO
Sold on a plan
19,500
$210.91K
8.1%
ZVRA ZEVRA THERAPEUTICS, INC.
14 Feb 2025
President and CEO
Sold on a plan
30,544
$245.96K
13.8%
ZVRA ZEVRA THERAPEUTICS, INC.
13 Feb 2025
President and CEO
Sold on a plan
61,273
$481.43K
21.6%
TVTX Travere Therapeutics, Inc.
16 May 2019
Chief Operating Officer
Sold, plan not stated
984
$18.41K
3.5%
TVTX Travere Therapeutics, Inc.
15 May 2019
Chief Operating Officer
Sold, plan not stated
984
$17.50K
3.4%
TVTX Travere Therapeutics, Inc.
20 Dec 2018
Chief Operating Officer
Sold, plan not stated
11,125
$248.33K
27.8%
TVTX Travere Therapeutics, Inc.
14 Nov 2018
Chief Operating Officer
Sold, plan not stated
10,000
$237.31K
26.0%
TVTX Travere Therapeutics, Inc.
16 Aug 2017
Chief Operating Officer
Sold, plan not stated
1,378
$31.01K
9.2%
10 decisions on file.